Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Sullivan

Showing results (111-120 of 201) with videos related to

Pageof 21
Sort By:
Journal of Medicinal Chemistry|April 15, 1994
Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activitiesD S Garvey, J T Wasicak, M W Decker, et al.
Gene|October 31, 2000
Molecular characterization of human SUR2-containing K(ATP) channelsR Davis-Taber, W Choi, J Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterizationS P Arneric, J P Sullivan, C A Briggs, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptorsJ P Sullivan, M W Decker, J D Brioni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humansA D Rodrigues, J L Ferrero, M T Amann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterizationM W Decker, J D Brioni, J P Sullivan, et al.
Life Sciences|January 15, 2002
Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral functionA B O'Neill, S A Buckner, M E Brune, et al.
Ecology Letters|July 9, 2025
Storms Are an Important Driver of Change in Tropical ForestsEvan M Gora, Ian R McGregor, Helene C Muller-Landau, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cellsM Gopalakrishnan, K L Whiteaker, E J Molinari, et al.
Zeitschrift Fur Physik. A, Atomic Nuclei|January 1, 1986
Measurements of n-p correlations in the reaction of relativistic neon with uraniumK Frankel, W Schimmerling, J O Rasmussen, et al.
Pageof 21

Showing results (111-120 of 201) with videos related to

Sort By:
Pageof 21
Journal of Medicinal Chemistry|April 15, 1994
Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activitiesD S Garvey, J T Wasicak, M W Decker, et al.
Gene|October 31, 2000
Molecular characterization of human SUR2-containing K(ATP) channelsR Davis-Taber, W Choi, J Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterizationS P Arneric, J P Sullivan, C A Briggs, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
(+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptorsJ P Sullivan, M W Decker, J D Brioni, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1994
The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humansA D Rodrigues, J L Ferrero, M T Amann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
(S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterizationM W Decker, J D Brioni, J P Sullivan, et al.
Life Sciences|January 15, 2002
Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral functionA B O'Neill, S A Buckner, M E Brune, et al.
Ecology Letters|July 9, 2025
Storms Are an Important Driver of Change in Tropical ForestsEvan M Gora, Ian R McGregor, Helene C Muller-Landau, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cellsM Gopalakrishnan, K L Whiteaker, E J Molinari, et al.
Zeitschrift Fur Physik. A, Atomic Nuclei|January 1, 1986
Measurements of n-p correlations in the reaction of relativistic neon with uraniumK Frankel, W Schimmerling, J O Rasmussen, et al.
Pageof 21